Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2013 Jul 17;94(6):10.1038/clpt.2013.143. doi: 10.1038/clpt.2013.143

Table 3.

Genetic association analysis for drug-induced liver injury (DILI) in 56 PAH patients treated with bosentan.

Odds ratio1 OR 95% CI lower limit OR 95% CI upper limit P
Age 0.94 0.86 1.04 0.24
Sex 1.21 0.09 68.2 1.00
BMI 0.96 0.83 1.11 0.62
Hx liver disease 0.00 0.00 18.2 1.00
Bosentan exposure 0.99 0.99 1.00 0.39
Co-medications 0.58 0.04 8.61 0.62
ABCC2
    rs717620 1.59 0.11 23.5 0.64
    rs2273697 0.46 0.01 6.18 0.64
    rs1885301 1.86 0.14 103 1.00
    rs7910642 0.00 0.00 8.41 1.00
    rs2804402 0.28 0.02 4.21 0.23
ABCB11
    rs2287622 0.45 0.03 6.74 0.59
SLCO1B1
    rs11045819 4.60 0.30 71.5 0.17
    rs2306283 2.01 0.15 112 1.00
    rs4149056 0.54 0.01 7.26 1.00
SLCO1B3
    rs7311358 0.83 0.02 11.2 1.00
CYP2C9
    *2/ rs1799853 2.29 0.003
    *3/ rs1057910 0.00 0.00 8.41 1.00
1

Odds ratio was calculated by logistic regression for continuous variables and by a Fisher exact test for dichotomous variables.